follow us:
The World Health Organization (WHO) has granted its first prequalification approval for a malaria treatment for infants. The drug, Artemether-lumefantrine, is designed to protect newborns and very young children from the mosquito-borne disease. Malaria remains a global threat, with about 282 million cases and over 610,000 deaths reported worldwide in 2024.
